FABP5 and prostate carcinoma: Therefore, we have been screening potential anti-cancer agents by assessing inhibitory activity for the gene expression of FABP5. Thus, the compounds which suppress the expression of FABP5 might be promising chemopreventive agents against prostate cancer metastasis.